BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38387708)

  • 1. Characterization of a germline variant TNS1 c.2999-1G > C in a hereditary cancer syndrome family.
    Di X; Wang D; Wu J; Zhu X; Wang Y; Yan J; Wen L; Jiang H; Wen D; Shu B; Zhang S
    Gene; 2024 May; 908():148304. PubMed ID: 38387708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A germline mutation in Rab43 gene identified from a cancer family predisposes to a hereditary liver-colon cancer syndrome.
    Jiang Y; Sun Y; Hu J; Yu N; Liu H; Fan J; Ning X; Li Y; Liu B; Sun Y; Zhang J; Qiu X; Fu S; Zhou C; Xu H
    BMC Cancer; 2019 Jun; 19(1):613. PubMed ID: 31226964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The spectrum of genetic variants in hereditary pancreatic cancer includes Fanconi anemia genes.
    Slavin TP; Neuhausen SL; Nehoray B; Niell-Swiller M; Solomon I; Rybak C; Blazer K; Adamson A; Yang K; Sand S; Guerrero-Llamas N; Castillo D; Herzog J; Wu X; Tao S; Raja S; Chung V; Singh G; Nadesan S; Brown S; Cruz-Correa M; Petersen GM; Weitzel J;
    Fam Cancer; 2018 Apr; 17(2):235-245. PubMed ID: 28687971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of germline genetic mutations in patients with pancreatic cancer.
    Salo-Mullen EE; O'Reilly EM; Kelsen DP; Ashraf AM; Lowery MA; Yu KH; Reidy DL; Epstein AS; Lincoln A; Saldia A; Jacobs LM; Rau-Murthy R; Zhang L; Kurtz RC; Saltz L; Offit K; Robson ME; Stadler ZK
    Cancer; 2015 Dec; 121(24):4382-8. PubMed ID: 26440929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel RBBP8(p.E281*) germline mutation is a predisposing mutation in familial hereditary cancer syndrome.
    Yan J; Wu J; Wang Y; Di X; Jiang H; Wen D; Li D; Zhang S
    J Mol Med (Berl); 2023 Oct; 101(10):1255-1265. PubMed ID: 37615686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic Cancer with Mutation in BRCA1/2, MLH1, and APC Genes: Phenotype Correlation and Detection of a Novel Germline BRCA2 Mutation.
    Vietri MT; D'Elia G; Caliendo G; Albanese L; Signoriello G; Napoli C; Molinari AM
    Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-Occurrence of Familial Non-Medullary Thyroid Cancer (FNMTC) and Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Associated Tumors-A Cohort Study.
    Aswath K; Welch J; Gubbi S; Veeraraghavan P; Avadhanula S; Gara SK; Dikoglu E; Merino M; Raffeld M; Xi L; Kebebew E; Klubo-Gwiezdzinska J
    Front Endocrinol (Lausanne); 2021; 12():653401. PubMed ID: 34326811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two unique BAP1 pathogenic variants identified in the same family by panel cascade testing.
    Byrne L; Ingalls C; Ansari A; Porteus C; Donenberg TR; Sussman DA; Cebulla CM; Abdel-Rahman MH
    Fam Cancer; 2023 Jul; 22(3):307-311. PubMed ID: 36513904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hereditary Cancer Syndrome in a Family with Double Mutation in
    D'Elia G; Caliendo G; Passariello L; Albanese L; Makker J; Molinari AM; Vietri MT
    Genes (Basel); 2023 Feb; 14(2):. PubMed ID: 36833355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATM whole gene deletion in an Italian family with hereditary pancreatic cancer: Challenges to cancer risk prediction associated with an 11q22.3 microdeletion.
    Arts HH; Lynch L; Grafodatskaya D; Eng B; Malloy L; Duck J; White R; Woodside C; Bell K; Zbuk KM; McCready E
    Cancer Genet; 2020 Jan; 240():1-4. PubMed ID: 31671381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of Germline Alterations in Appendiceal Adenocarcinoma.
    Foote MB; Walch H; Kemel Y; Vakiani E; Johannet P; Sheehan M; Chatila W; Chung S; Nash GM; Maio A; Shia J; Mandelker D; Berger M; Schultz N; Diaz LA; Cercek A; Stadler ZK
    Clin Cancer Res; 2023 Jul; 29(14):2631-2637. PubMed ID: 37289003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective study of germline genetic testing in incident cases of pancreatic adenocarcinoma.
    Brand R; Borazanci E; Speare V; Dudley B; Karloski E; Peters MLB; Stobie L; Bahary N; Zeh H; Zureikat A; Hogg M; Lee K; Tsung A; Rhee J; Ohr J; Sun W; Lee J; Moser AJ; DeLeonardis K; Krejdovsky J; Dalton E; LaDuca H; Dolinsky J; Colvin A; Lim C; Black MH; Tung N
    Cancer; 2018 Sep; 124(17):3520-3527. PubMed ID: 30067863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive analysis of candidate genes in familial pancreatic cancer families reveals a high frequency of potentially pathogenic germline variants.
    Earl J; Galindo-Pumariño C; Encinas J; Barreto E; Castillo ME; Pachón V; Ferreiro R; Rodríguez-Garrote M; González-Martínez S; Ramon Y Cajal T; Diaz LR; Chirivella-Gonzalez I; Rodriguez M; de Castro EM; García-Seisdedos D; Muñoz G; Rosa JMR; Marquez M; Malats N; Carrato A
    EBioMedicine; 2020 Mar; 53():102675. PubMed ID: 32113160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected pancreatic cancer.
    Yurgelun MB; Chittenden AB; Morales-Oyarvide V; Rubinson DA; Dunne RF; Kozak MM; Qian ZR; Welch MW; Brais LK; Da Silva A; Bui JL; Yuan C; Li T; Li W; Masuda A; Gu M; Bullock AJ; Chang DT; Clancy TE; Linehan DC; Findeis-Hosey JJ; Doyle LA; Thorner AR; Ducar MD; Wollison BM; Khalaf N; Perez K; Syngal S; Aguirre AJ; Hahn WC; Meyerson ML; Fuchs CS; Ogino S; Hornick JL; Hezel AF; Koong AC; Nowak JA; Wolpin BM
    Genet Med; 2019 Jan; 21(1):213-223. PubMed ID: 29961768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burden of hereditary cancer susceptibility in unselected patients with pancreatic ductal adenocarcinoma referred for germline screening.
    Cremin C; Lee MK; Hong Q; Hoeschen C; Mackenzie A; Dixon K; McCullum M; Nuk J; Kalloger S; Karasinska J; Scudamore C; Kim PTW; Donnellan F; Lam ECS; Lim HJ; Neben CL; Stedden W; Zhou AY; Schaeffer DF; Sun S; Renouf DJ; Schrader KA
    Cancer Med; 2020 Jun; 9(11):4004-4013. PubMed ID: 32255556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis of germline mutations in northern Brazil: a panel of 16 genes for hereditary cancer-predisposing syndrome investigation.
    Vidal AF; Ferraz RS; El-Husny A; Silva CS; Vinasco-Sandoval T; Magalhães L; Raiol-Moraes M; Barra WF; Pereira CLBL; de Assumpção PP; de Brito LM; Vialle RA; Santos S; Ribeiro-Dos-Santos Â; Ribeiro-Dos-Santos AM
    BMC Cancer; 2021 Apr; 21(1):363. PubMed ID: 33827469
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Martín-Morales L; Garre P; Lorca V; Cazorla M; Llovet P; Bando I; García-Barberan V; González-Morales ML; Esteban-Jurado C; de la Hoya M; Castellví-Bel S; Caldés T
    Cancer Prev Res (Phila); 2021 Feb; 14(2):185-194. PubMed ID: 33115781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline sequence analysis of RABL3 in a large series of pancreatic ductal adenocarcinoma patients reveals no evidence of deleterious variants.
    Roberts NJ; Grant RC; Gallinger S; Klein AP;
    Genes Chromosomes Cancer; 2021 Aug; 60(8):559-564. PubMed ID: 33724601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surveillance of patients with hereditary gastrointestinal cancer syndromes.
    Moreira L; Castells A
    Best Pract Res Clin Gastroenterol; 2016 Dec; 30(6):923-935. PubMed ID: 27938787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Features and Clinical Management of Hereditary Pancreatic Cancer Syndromes and Familial Pancreatic Cancer.
    Kasuga A; Okamoto T; Udagawa S; Mori C; Mie T; Furukawa T; Yamada Y; Takeda T; Matsuyama M; Sasaki T; Ozaka M; Ueki A; Sasahira N
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.